Rare Diseases: New Help for Patients Without Treatments

Years ago, people diagnosed with a rare disease might have found themselves
with little hope for a medical treatment. This changed in 1983 when American Congress
passed the Orphan Drug Act, a law that offered drug companies special
incentives to develop products for treating diseases with fewer than 200,000
patients a year. The inducements include seven-year marketing exclusivity, tax
credit for the product-associated clinical research, research design assistance
by the FDA, and grants of up to $300,000 per year.

Marjolin’s carcinoma cured with hekla lava

Marjolin initially described malignant transformation of a chronic scar from a burn wound. But presently, the term Marjolin ulcer has been used interchangeably for malignant transformation of any chronic wound, including pressure sores, osteomyelitis, venous stasis ulcers, urethral fistulas, anal fistulas, and other traumatic wounds. This malignant transformation is, histologically, a well-differentiated squamous cell carcinoma.

Vitiligo :: Efficacy of Homoeopathic Drugs in cases of Leucoderma – Vitiligo

Six hundred and ninety five (695) patients suffering from leucoderma were registered for treatment at Gaurang Clinic & Centre for Homoeopathic Research, Lucknow from April 1996 to March 2001 out of which a total of five hundred and sixty (560) patients were available for proper follow up of treatment and analysis to assess the percent response by treatment with homoeopathic drugs.

continue reading